HMOX1 and cancer: In contrast, cancer cells treated with CM-EXOs exhibited significantly downregulated expression of antioxidant-related genes (NrF2 and HO-1), with lowest expression in cells treated with highest dose of EXOs (EXO-H), relative to the control cells (Figure 6).